Fatal non-occlusive mesenteric ischemia after esophagectomy.
Non-occlusive mesenteric ischemia (NOMI) is a disorder with an extremely high mortality. Salvage of affected patients requires early recognition and aggressive intervention to prevent intestinal gangrene. We present a case of NOMI developing after esophagectomy and discuss the pathophysiology diagnosis and therapy.
Qureshi
Sajid S
SS
Department of Thoracic Services, Tata Memorial Hospital, Mumbai, India.
Neve
Rakesh S
RS
Raina
Sudip A
SA
Mistry
Rajesh C
RC
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000601:surgery; D004938:Esophageal Neoplasms / Q000601:surgery; D016629:Esophagectomy / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D007511:Ischemia / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008638:Mesenteric Arteries / Q000473:pathology / Q000503:physiopathology; D008641:Mesenteric Vascular Occlusion / Q000209:etiology* / Q000473:pathology* / Q000503:physiopathology; D008642:Mesenteric Veins / Q000473:pathology / Q000503:physiopathology; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D009566:Nitrates / Q000627:therapeutic use; D011183:Postoperative Complications / Q000473:pathology* / Q000503:physiopathology; D014665:Vasodilator Agents / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D009566:Nitrates; D014665:Vasodilator Agents